Please use this identifier to cite or link to this item: http://archive.cmb.ac.lk:8080/xmlui/handle/70130/5613
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRanganathan, Shilani Sri-
dc.date.accessioned2021-07-30T06:48:01Z-
dc.date.available2021-07-30T06:48:01Z-
dc.date.issued2001-
dc.identifier.citationRanganathan, S. S. (2001). Drug related Iatrogenic disease: the specal vulnerability of children.en_US
dc.identifier.urihttp://archive.cmb.ac.lk:8080/xmlui/handle/70130/5613-
dc.description.abstractOnly about 2500 people will have been exposed to a drug before it is marketed and the chance of finding an adverse reaction with an incidence oF less than 1 /1000 prior to marketing is therefore small. . Drugs may not be extensively tested in children so that many medicines given to children are not licensed for a particular indication' age of the child, or presented in a suitable formulation or route of administration . The use of'off label' or unlicensed drugs to treat children is widespread throughout Europe so that continued monitoring is essential to detect the adverse drug reacdons in children' . The Yellow Card Scheme is an important mechanism for doctors and pharmacists to rePort their suspicions about a possible adverse drug reaction and allow early detection of an adverse effect. . Early detection and reporting of suspected adverse drug reactions by doctors caring for children will prevent other children experiencing adverse drug reacdons. . Regrettably Paediatricians and other doctors caring for children seem to have a poor record for completing Yellow Cards although there is no hard evidence for this. To improve our knowledge and understanding of drug safety in children' we must have comPrehensive rePorting' A recent circulated self assessment bulletin on which the article is based to paediatricians in'\(ales is an intervention to improve rePorting of adverse side effects ofdrugs given to children'en_US
dc.subjectIatrogenic diseasen_US
dc.subjectDrugsen_US
dc.subjectChildrenen_US
dc.subjectYellow Card Schemen_US
dc.titleDrug related Iatrogenic disease: the specal vulnerability of childrenen_US
dc.typeArticleen_US
Appears in Collections:Articles (local / International)

Files in This Item:
File Description SizeFormat 
Drug related Iatrogenic disease the specal vulnerability of children.pdf4.89 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.